Autopsy report · NCT00035581
Safety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART
Cause of deathNo reason given
Life of this trial
- Registered 1 year after it had already started.
- Ran for about 4 years 4 months before it stopped.
- 16 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- AIM ImmunoTech Inc.
- Sponsor type
- Industry
- Conditions
- HIV Seropositivity; HIV Infection
- Interventions
- poly I-poly C12U
- Participants
- 16
- Sites
- 7
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.